108 related articles for article (PubMed ID: 10761707)
1. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.
Shibuta K; Inoue H; Sato K; Matsuyama A; Ueo H; Tanaka Y; Mafune K; Barnard GF; Mori M
Jpn J Cancer Res; 2000 Feb; 91(2):199-203. PubMed ID: 10761707
[TBL] [Abstract][Full Text] [Related]
2. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer.
Shibuta J; Eto T; Kataoka A; Inoue H; Ueo H; Suzuki T; Barnard GF; Mori M
Am J Gastroenterol; 2001 Dec; 96(12):3419-24. PubMed ID: 11774959
[TBL] [Abstract][Full Text] [Related]
4. Different susceptibility of each L-myc genotype to esophageal cancer risk factors.
Kumimoto H; Hamajima N; Nishizawa K; Nishimoto Y; Matsuo K; Harada H; Shinoda M; Hatooka S; Ishizaki K
Jpn J Cancer Res; 2001 Jul; 92(7):735-9. PubMed ID: 11473723
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
[TBL] [Abstract][Full Text] [Related]
6. Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer.
Isbir T; Yaylim I; Arikan S; Kaytan E; Karşidağ T; Bayrak S; Camlica H
Cancer Detect Prev; 2002; 26(6):454-7. PubMed ID: 12507230
[TBL] [Abstract][Full Text] [Related]
7. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
[TBL] [Abstract][Full Text] [Related]
8. L-myc gene polymorphism and risk of thyroid cancer.
Yaylim-Eraltan I; Bozkurt N; Ergen A; Zeybek U; Ozturk O; Arikan S; Erbil Y; Uslu I; Camlica H; Isbir T
Exp Oncol; 2008 Jun; 30(2):117-20. PubMed ID: 18566574
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of the S-allele of the L-myc oncogene in breast cancer.
Isbir T; Yaylim I; Arîkan S; Küçücük S; Camlíca H
Mol Med; 2002 Sep; 8(9):521-4. PubMed ID: 12456990
[TBL] [Abstract][Full Text] [Related]
10. Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer.
Shibuta K; Nakashima T; Abe M; Mashimo M; Mori M; Ueo H; Akiyoshi T; Sugimachi K; Suzuki T
Cancer; 1994 Dec; 74(12):3108-12. PubMed ID: 7982175
[TBL] [Abstract][Full Text] [Related]
11. [MTHFR C677T polymorphism and genetic susceptibility of esophageal cancer and esophageal precancerous lesions].
Huang G; Wang S; Su M; Wang T; Yin H; Sun G
Wei Sheng Yan Jiu; 2014 Mar; 43(2):254-8. PubMed ID: 24868979
[TBL] [Abstract][Full Text] [Related]
12. EcoRI polymorphism of the L-myc gene in gastric cancer patients.
Dlugosz A; Adler G; Ciechanowicz A; Jaroszewicz-Heigelmann H; Starzynska T
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1231-5. PubMed ID: 12439118
[TBL] [Abstract][Full Text] [Related]
13. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in genitourinary cancers.
Kakehi Y; Taki Y; Yoshida O
Urol Int; 1991; 47 Suppl 1():86-9. PubMed ID: 1683040
[TBL] [Abstract][Full Text] [Related]
14. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
[TBL] [Abstract][Full Text] [Related]
15. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.
Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen A; Hafiz G; Karadeniz A; Isbir T
Anticancer Res; 2009 Jul; 29(7):2519-24. PubMed ID: 19596922
[TBL] [Abstract][Full Text] [Related]
16. [Serum level and genotype of interleukin-6 in patients with esophageal cancer].
Tang RG; Wei YS; Chen HM; Fang WZ; Long XK; Yuan XH
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1126-8. PubMed ID: 17672997
[TBL] [Abstract][Full Text] [Related]
17. Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: a case-control study and meta-analysis.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
J Gastroenterol Hepatol; 2013 Nov; 28(11):1717-24. PubMed ID: 23869757
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of common genetic variants in pre-microRNA in susceptibility and prognosis of esophageal cancer.
Umar M; Upadhyay R; Prakash G; Kumar S; Ghoshal UC; Mittal B
Mol Carcinog; 2013 Nov; 52 Suppl 1():E10-8. PubMed ID: 22692992
[TBL] [Abstract][Full Text] [Related]
19. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
20. Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma patients.
Ge H; Lam WK; Lee J; Wong MP; Yew WW; Lung ML
Lung Cancer; 1996 Nov; 15(3):355-66. PubMed ID: 8959680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
